mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.07 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.07 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.07 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.07 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |